{"id":221959,"date":"2020-05-01T08:22:21","date_gmt":"2020-05-01T13:22:21","guid":{"rendered":"https:\/\/www.liveaction.org\/news\/?p=221959"},"modified":"2022-04-21T07:02:59","modified_gmt":"2022-04-21T12:02:59","slug":"no-test-contact-abortion-covid-works-time","status":"publish","type":"post","link":"https:\/\/archive.liveaction.org\/news\/no-test-contact-abortion-covid-works-time\/","title":{"rendered":"‘No test’ abortion isn’t the abortion industry’s response to COVID-19. They planned it years ago."},"content":{"rendered":"
<\/div>

For several months, pro-abortion groups have been working to expand abortion pill access and to lift the U.S. Food and Drug Administration’s (FDA) safety system known as Risk Evaluation and Mitigation Strategy (REMS). The abortion industry is now pushing a “no test” abortion pill protocol, detailed here<\/a> and here<\/a>. While the industry would like the public to believe the “no test” protocol was put in place because of COVID-19, the plan has actually been in the works for a long time.<\/p>\n

At a 2019\u00a0panel discussion<\/a>\u00a0at the taxpayer-funded<\/a> University of California’s Bixby Center for Global Reproductive Health, abortion providers detailed efforts to remove all testing for women (including ultrasounds, exams, and blood work) before dispensing the abortion pill. At that event, Dr. Ushma Upadhyay, Associate Professor at Advancing New Standards in Reproductive Health (ANSIRH), advocated a “believe the woman” approach — meaning that the woman, not the abortionist, would bear the burden of determining her child’s gestational age. Watch the video<\/a>\u00a0below at 1:30:00:<\/span><\/p>\n